- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Combination of NKTR-214 nivolumab
Total 7585 results
-
Nektar TherapeuticsBristol-Myers SquibbCompletedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | HR+/HER2- Breast CancerUnited States, Spain, Canada, France, Italy, Belgium, Poland, United Kingdom
-
Nektar TherapeuticsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Calithera Biosciences, IncNektar TherapeuticsWithdrawnLymphoma, Non-HodgkinUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Stanford University; Rockefeller UniversityActive, not recruiting
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Bristol-Myers SquibbOno Pharmaceutical Co. Ltd; Nektar TherapeuticsCompleted
-
Nektar TherapeuticsCompletedCovid-19 | Coronavirus Disease 2019United States
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
Bristol-Myers SquibbNektar TherapeuticsTerminatedEwing Sarcoma | Ependymoma | Medulloblastoma | Neuroblastoma | Rhabdomyosarcoma | High-grade Glioma | Leukemia and Lymphoma | Miscellaneous Brain Tumors | Miscellaneous Solid Tumors | Relapsed, Refractory Malignant NeoplasmsUnited States, Australia, France, Germany, Italy, Spain
-
Nektar TherapeuticsBristol-Myers SquibbCompletedNeoplasm Metastasis | Urinary Bladder NeoplasmUnited States, Spain, United Kingdom, Belgium, Canada, Australia, France, Italy, Greece, Germany, Portugal, Argentina, Israel, Russian Federation, Turkey, Mexico, Finland, Netherlands
-
Nektar TherapeuticsImaginAb, Inc.Withdrawn
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
Bristol-Myers SquibbNektar TherapeuticsCompletedBladder Cancer | Bladder Tumor | Muscle-Invasive Bladder CancerRussian Federation, China, Germany, Italy, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Greece, Israel, Mexico, Netherlands, Poland, Spain, United Kingdom
-
Nektar TherapeuticsTerminatedMelanoma | Sarcoma | Renal Cell Carcinoma | Colorectal Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Merkel Cell CarcinomaUnited States
-
Jason J. Luke, MDArray BioPharmaActive, not recruitingMelanoma | Renal Cell Carcinoma | Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell CarcinomaUnited States
-
University of Wisconsin, MadisonNektar TherapeuticsTerminatedHead and Neck CancerUnited States
-
HUYABIO International, LLC.Bristol-Myers SquibbRecruitingUnresectable or Metastatic Melanoma | Progressive Brain MetastasisSpain, United States, Italy, Japan, Belgium, France, New Zealand, Brazil, Korea, Republic of, Australia, Germany, Singapore, Czechia, Austria, South Africa, United Kingdom, Puerto Rico
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York CityCompletedAdvanced Metastatic Cancer | Advanced Prostate CancerUnited States
-
Parker Institute for Cancer ImmunotherapyBristol-Myers Squibb; Cancer Research Institute, New York City; Celldex Therapeutics and other collaboratorsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbActive, not recruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Celldex TherapeuticsBristol-Myers SquibbCompletedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Ovarian Carcinoma-Enrollment Completed | Colorectal Cancer (CRC)-Enrollment Completed | Renal Cell Carcinoma (RCC) (Phase ll Only) | Glioblastoma (GBM) (Phase ll Only)-Enrollment CompletedUnited States
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
Bristol-Myers SquibbCompletedLung CancerItaly, United States, France, Russian Federation, Spain, Argentina, Belgium, Brazil, Canada, Chile, Czechia, Germany, Greece, Hungary, Mexico, Netherlands, Poland, Romania, Switzerland, Turkey, United Kingdom
-
HUYABIO International, LLC.CompletedMelanoma | Renal Cell Carcinoma | Non-Small Cell Lung CancerUnited States
-
Yale UniversityBristol-Myers SquibbCompletedCarcinoma, Non-Small-Cell LungUnited States
-
Celleron Therapeutics Ltd.UnknownColorectal Neoplasms MalignantUnited Kingdom
-
Hospital Universitario Dr. Jose E. GonzalezRecruitingSafety Issues | Efficacy, SelfMexico
-
Nektar TherapeuticsCompletedOvarian Cancer | TumorUnited States, Belgium, United Kingdom
-
Bristol-Myers SquibbRecruiting
-
Compugen LtdBristol-Myers SquibbActive, not recruitingHead and Neck Cancer | Ovarian Cancer | Solid Tumor | Endometrial NeoplasmsUnited States
-
Yale UniversityBristol-Myers SquibbActive, not recruitingSmall Cell Lung CancerUnited States
-
Zhejiang UniversityRecruitingAdvanced Pancreatic CancerChina
-
National University Hospital, SingaporeRecruitingMetastatic Solid Malignancies | Advance Solid MalignanciesSingapore
-
Yonsei UniversityUnknownMelanomaKorea, Republic of
-
CelgeneActive, not recruitingNon Small Cell Lung CancerUnited States
-
Clinica Universidad de Navarra, Universidad de...Highlight TherapeuticsRecruitingNon-Small Cell Lung Cancer MetastaticSpain
-
AbbVieAbbVieRecruiting
-
Centre Hospitalier Annecy GenevoisFrench Lung Cancer GroupActive, not recruitingCarcinoma, Non-Small-Cell Lung | Bone MetastasesFrance
-
AIO-Studien-gGmbHCompleted
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
Akamis BioBristol-Myers SquibbRecruitingMetastatic Cancer | Epithelial TumorUnited States, United Kingdom
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruiting
-
Intergruppo Melanoma ItalianoActive, not recruiting
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Melanoma Institute AustraliaBristol-Myers SquibbNot yet recruitingCutaneous Squamous Cell Carcinoma
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom
-
Institut Claudius RegaudCompleted
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States